These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 29571584)

  • 1. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
    Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
    Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
    Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
    Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
    Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
    J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered methylation of multiple genes in carcinogenesis of the prostate.
    Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
    Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
    Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
    Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation profile of GSTP1 and RASSF1A in prostate cancerand benign hyperplasia in Vietnamese men.
    Vo TT; Ta BT; Ta VT; Vuong DL; Nguyen QU
    Turk J Med Sci; 2016 Jan; 46(1):228-35. PubMed ID: 27511358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.
    Dimitriadis E; Kalogeropoulos T; Velaeti S; Sotiriou S; Vassiliou E; Fasoulis L; Klapsas V; Synesiou M; Apostolaki A; Trangas T; Pandis N
    Anticancer Res; 2013 Jan; 33(1):191-7. PubMed ID: 23267145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA.
    Abramovic I; Pezelj I; Dumbovic L; Skara Abramovic L; Vodopic T; Bulimbasic S; Stimac G; Bulic-Jakus F; Kulis T; Katusic Bojanac A; Tomas D; Ulamec M; Sincic N
    Prostate; 2024 Sep; 84(12):1128-1137. PubMed ID: 38824441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Clinicopathological Aspects of Prostate Cancer in Bulgarian Probands.
    Tsvetkova A; Todorova A; Todorov T; Georgiev G; Drandarska I; Mitev V
    Pathol Oncol Res; 2015 Sep; 21(4):969-76. PubMed ID: 25753984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer.
    Hashad DI; Hashad MM; Talaat IM; Ibrahim MA
    Genet Test Mol Biomarkers; 2011 Oct; 15(10):667-70. PubMed ID: 21631298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
    Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
    Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
    Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype-phenotype relationship.
    Kizilay F; Kalemci MS; Şimşir A; Turna B; Nazli O; Berdeli A
    Turk J Med Sci; 2014; 44(2):261-6. PubMed ID: 25536734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of androgen receptor CAG repeats with the risks of benign prostatic hyperplasia and prostate cancer: a meta-analysis].
    Wang XM; Sun L; Zhang Z; Shi XH; Zhang YG; Wei D; Wan B; Yang Z; Wang JY
    Zhonghua Nan Ke Xue; 2014 Feb; 20(2):172-6. PubMed ID: 24520673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.